In line with MET induction of ING5 in lung cancer [11], and glioma [17], ING5 overexpression was demonstrated to markedly decrease the ability of breast cancer cells to migrate and invade with E-cadherin overexpression and N-cadherin hypoexpression at both mRNA and protein levels. The gene discussed is CDH2; the disease is glioma.